OBJECTIVE: Depression is common among persons with heart failure (HF) and has been linked to cognitive impairment in this population. The mechanisms of this relationship are unclear, and the current study examined whether cerebral perfusion moderates the association between depressive symptoms and cognitive impairment in patients with HF. METHODS: Persons with HF (n = 89; mean [standard deviation] age = 67.61 [11.78] years) completed neuropsychological testing and impedance cardiography. Depressive symptoms were assessed using the Beck Depression Inventory II, and transcranial Doppler was used to quantify cerebral perfusion. RESULTS: Depression was associated with reduced performance on tasks assessing attention/executive function (r = -0.28), language (r = -0.0.30), and motor function (r = -0.28) in unadjusted models (p values <.05). Global cerebral blood flow was correlated with memory performance (r = 0.22, p = .040) but not with other tasks. A moderation analysis was performed using hierarchical regression models for attention/executive function, memory, language, and motor function. For each model, medical and demographic characteristics were entered into the initial blocks, and the final block consisted of an interaction term between global cerebral blood flow velocity and the Beck Depression Inventory II. The interaction between greater depressive symptoms and decreased global cerebral blood flow velocity was associated with greater deficits in attention/executive function (β = .32, ΔR(2) = 0.08, p = .003). CONCLUSIONS: Depressive symptoms and cerebral hypoperfusion interact to adversely affect cognitive performance in older adults with HF. Longitudinal studies are needed to clarify this relationship and elucidate subsequent neuropathology.
OBJECTIVE:Depression is common among persons with heart failure (HF) and has been linked to cognitive impairment in this population. The mechanisms of this relationship are unclear, and the current study examined whether cerebral perfusion moderates the association between depressive symptoms and cognitive impairment in patients with HF. METHODS:Persons with HF (n = 89; mean [standard deviation] age = 67.61 [11.78] years) completed neuropsychological testing and impedance cardiography. Depressive symptoms were assessed using the Beck Depression Inventory II, and transcranial Doppler was used to quantify cerebral perfusion. RESULTS:Depression was associated with reduced performance on tasks assessing attention/executive function (r = -0.28), language (r = -0.0.30), and motor function (r = -0.28) in unadjusted models (p values <.05). Global cerebral blood flow was correlated with memory performance (r = 0.22, p = .040) but not with other tasks. A moderation analysis was performed using hierarchical regression models for attention/executive function, memory, language, and motor function. For each model, medical and demographic characteristics were entered into the initial blocks, and the final block consisted of an interaction term between global cerebral blood flow velocity and the Beck Depression Inventory II. The interaction between greater depressive symptoms and decreased global cerebral blood flow velocity was associated with greater deficits in attention/executive function (β = .32, ΔR(2) = 0.08, p = .003). CONCLUSIONS:Depressive symptoms and cerebral hypoperfusion interact to adversely affect cognitive performance in older adults with HF. Longitudinal studies are needed to clarify this relationship and elucidate subsequent neuropathology.
Authors: Tatyana G Jones; John A Schinka; Rodney D Vanderploeg; Brent J Small; Amy Borenstein Graves; James A Mortimer Journal: Arch Clin Neuropsychol Date: 2002-02 Impact factor: 2.813
Authors: Peter de Jonge; Johan Ormel; Rob H S van den Brink; Joost P van Melle; Titia A Spijkerman; Astrid Kuijper; Dirk J van Veldhuisen; Maarten P van den Berg; Adriaan Honig; Harry J G M Crijns; Aart H Schene Journal: Am J Psychiatry Date: 2006-01 Impact factor: 18.112
Authors: J R C Almeida; T C T F Alves; M Wajngarten; J Rays; C C Castro; Q Cordeiro; R M S Telles; R J Fraguas; G F Busatto Journal: Braz J Med Biol Res Date: 2005-03-08 Impact factor: 2.590
Authors: Tânia C T F Alves; Jairo Rays; Renério Fráguas; Mauricio Wajngarten; José C Meneghetti; Silvana Prando; Geraldo F Busatto Journal: J Neuroimaging Date: 2005-04 Impact factor: 2.486
Authors: Raymond L C Vogels; Wiesje M van der Flier; Barbera van Harten; Alida A Gouw; Philip Scheltens; Jutta M Schroeder-Tanka; Henry C Weinstein Journal: Eur J Heart Fail Date: 2007-08-23 Impact factor: 15.534
Authors: Michael L Alosco; Mary Beth Spitznagel; Lindsay Miller; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Donna Waechter; Joel Hughes; Jim Rosneck; John Gunstad Journal: Health Psychol Date: 2012-08-27 Impact factor: 4.267
Authors: Suzanne Persoon; L Jaap Kappelle; Bart N M van Berckel; Ronald Boellaard; Cyrille H Ferrier; Adriaan A Lammertsma; Catharina J M Klijn Journal: EJNMMI Res Date: 2012-06-09 Impact factor: 3.138
Authors: Michael L Alosco; Mary Beth Spitznagel; Ronald Cohen; Naftali Raz; Lawrence H Sweet; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad Journal: Int J Geriatr Psychiatry Date: 2013-09-10 Impact factor: 3.485
Authors: Michael L Alosco; Mary Beth Spitznagel; Ronald Cohen; Lawrence H Sweet; Scott M Hayes; Richard Josephson; Joel Hughes; John Gunstad Journal: J Card Fail Date: 2015-01-05 Impact factor: 5.712
Authors: Misty A W Hawkins; Emily C Gathright; John Gunstad; Mary A Dolansky; Joseph D Redle; Richard Josephson; Shirley M Moore; Joel W Hughes Journal: Heart Lung Date: 2014-07-14 Impact factor: 2.210
Authors: Misty A W Hawkins; Mary A Dolansky; Julie T Schaefer; Michael J Fulcher; John Gunstad; Joseph D Redle; Richard Josephson; Joel W Hughes Journal: J Cardiovasc Nurs Date: 2015 Sep-Oct Impact factor: 2.083
Authors: Michael L Alosco; John Gunstad; Courtney Beard; Xiaomeng Xu; Uraina S Clark; Donald R Labbe; Beth A Jerskey; Maura Ladino; Denise M Cote; Edward G Walsh; Athena Poppas; Ronald A Cohen; Lawrence H Sweet Journal: J Geriatr Psychiatry Neurol Date: 2014-07-09 Impact factor: 2.680
Authors: Laura S Redwine; Meredith A Pung; Kathleen Wilson; Katherine J Bangen; Lisa Delano-Wood; Barry Hurwitz Journal: J Psychosom Res Date: 2019-11-26 Impact factor: 3.006
Authors: Eiran Z Gorodeski; Parag Goyal; Scott L Hummel; Ashok Krishnaswami; Sarah J Goodlin; Linda L Hart; Daniel E Forman; Nanette K Wenger; James N Kirkpatrick; Karen P Alexander Journal: J Am Coll Cardiol Date: 2018-05-01 Impact factor: 24.094